Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Agnoletti, L.
Right arrow Articles by Ferrari, R.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Agnoletti, L.
Right arrow Articles by Ferrari, R.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

The European Society of Cardiology

Immune activation in severe heart failure

Does etiology play a role?

Laura Agnolettia, Salvatore Curellob, Fabio Malacarnec, Paolo Airòc, Anna Cargnonia, Marco Valgimiglid and Roberto Ferrarid,*,1

a Cardiovascular Pathophysiology Research Center, S. Maugeri Foundation IRCCS, Gussago, Brescia, Italy
b Chair of Cardiology, Spedali Civili, Brescia, Italy
c Immunology Department, Spedali Civili, Brescia, Italy
d Chair of Cardiology, Cardiovascular Pathophysiology Research Center, S. Maugeri Foundation IRCCS and University of Ferrara, Via Pinidolo 23, 25064 Gussago, Brescia, Italy

* Correspondence: Tel.: +39 30 252 8391; fax: +39 30 252 2362 (E-mail: fri{at}dns.unife.it).

Abstract

AIM: Immune activation in severe congestive heart failure (CHF) due to idiopathic conditions is a well-known phenomenon. The question remains: is it confined to a specific aetiology or is a disease-dependent derangement? We investigated immune alterations in ischaemic compared to idiopathic patients with CHF and healthy subjects.

METHODS AND RESULTS: We evaluated alterations of immune activation studying both in vivo and in vitro parameters. In both idiopathic and ischaemic CHF patients: (a) lymphocyte count was reduced (P<0.01); (b) lymphocyte subsets were altered (CD4/CD8 ratio increased vs. controls: 2.53±0.8 and 3.3±2.1% in idiopathic and ischaemic patients, vs. 1.8±0.6% in controls; P<0.01); (c) lymphocytes from patients underwent a higher apoptosis (27.1±4.3% in idiopathic CHF and 25.4±3.5% in ischaemic CHF vs. 4.5±1.4%; P<0.0001); (d) TNF-α production from lymphocytes and monocytes of patients was higher than controls. A positive correlation was observed between TNF-α from monocytes of patients and the relevant serum levels (r=0.58; P<0.01); (e) conditioned media of lymphocytes and monocytes from patients significantly increased rate of endothelial apoptosis.

CONCLUSIONS: In severe CHF, irrespectively from aetiology, significant activation of immune system occurs: several pro-inflammatory cytokines and soluble factors are spontaneously released in serum, possibly contributing to disease progression, as they induce apoptosis.

Keywords Congestive heart failure; Immune system activation; TNF-α


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.